what is tecentriq approved for?
610063
TECENTRIQ, as a single agent, is indicated for the first-line treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have high PD-L1 expression (PD-L1–stained ≥50% of tumor cells [TC ≥50%] or PD-L1–stained tumor-infiltrating immune cells [IC] covering ≥10% of the tumor area [IC ≥10 ...
803559
Xtandi Patient Assistance Program Enzalutamide has been approved for use by Health Canada and has been recommended for funding by the pan-Canadian Oncology Drug Review (pCODR) for both indications.
1047793
Thrombate III is approved by the FDA for the treatment of patients with hereditary AT deficiency in connection with surgical or obstetrical procedures or with thromboembolism. ATryn is indicated for the prevention of perioperative and peripartum thromboembolic events in hereditary AT-deficient patients.
541094
Colchicine (Colcrys® or Mitigare®) is the only medication approved by the FDA to both treat and prevent gout flares. It interferes with the interactions between monosodium urate crystals and the surfaces of cells they encounter in your joint, so it “interrupts” the inflammatory reaction to these crystals.
1448344
Is the TIF procedure FDA Approved? Yes, the FDA gave clearance for the TIF procedure in 2007 for the treatment of chronic reflux (GERD) in patients who require and respond to medical drug therapy.
1391417
Myrbetriq works on a different pathway Myrbetriq is the only OAB treatment in its class that targets the beta-3 pathway to increase bladder capacity. When taken as directed, Myrbetriq can: Help relax the smooth muscle that surrounds the bladder. Help the bladder to fill more completely and increase urine storage.
626802
TEVA 3109 is the imprint on certain capsules of amoxicillin, a common drug for treating bacterial infections. The label “TEVA 3109” on the capsule doesn't make these pills a certain kind of amoxicillin; it just indicates who produced them. A TEVA 3109 pill is the same as any other amoxicillin pill.
676053
How Lamictal (Lamotrigine) Works to Treat Bipolar and Seizure Disorders. Lamictal (lamotrigine), a mood stabilizer and anticonvulsant, is not approved by the U.S. Food and Drug Administration (FDA) for the treatment of any anxiety disorders. It is approved to treat bipolar disorder and seizure disorders.
1130111
3.9% for Humira) and cerebrocardiovascular events (1.1% for Taltz vs. 1.8% for Humira). No new safety signals were detected. Taltz is approved for the treatment of adults with active psoriatic arthritis.
1257678
At this moment, MONQ is not FDA approved because our personal essential oil diffusers fall under the category within the aromatherapy industry that does not require FDA approval. Visit MONQ.com/safety to learn more about our safety measures and research.
1395757
Imfinzi is approved for the treatment of unresectable, Stage III non-small cell lung cancer in more than 45 countries, including the US, EU and Japan, based on the Phase III PACIFIC trial. Since the first approval in February 2018, more than 20,000 patients in this setting have been treated with Imfinzi.
993466
TEVA 3109 pills can treat a wide range of bacterial infections, including ear infections, pneumonia, bladder infections, gonorrhea, bronchitis, tonsillitis, strep throat, skin infections, urinary tract infections, salmonella infection, and blood poisoning.
373209
The OraQuick In-Home HIV Test is the only HIV test approved by the FDA that people can use to test themselves at home or in a private location. OraQuick was approved in 2012 for sale in stores and online to anyone age 17 and older. The kit does not require sending a sample to a lab.
1396135
EECP has been approved by the United States Food and Drug Administration (FDA) for the management of refractory angina (Class IIb). About 200 hospitals across India have adopted this technique.
318005
Bydureon Approved for Use With Basal Insulin for Uncontrolled T2D. AstraZeneca announced that the Food and Drug Administration (FDA) has approved Bydureon (exenatide extended-release for injectable suspension) as an add-on to basal insulin in adults with type 2 diabetes who have inadequate glycemic control.
1288925
Blood pressure drug recall: Teva pulls losartan tablets tainted with possible carcinogen. Teva Pharmaceuticals this week expanded its recall of losartan potassium tablets after detecting a possible human carcinogen in the blood pressure medication.
636541
Project Orbis: FDA approves acalabrutinib for CLL and SLL. On November 21, 2019, the Food and Drug Administration approved acalabrutinib (CALQUENCE, AstraZeneca) for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).